Showing 4651-4660 of 5646 results for "".
- John Weiss Secures Exclusive UK Distributorship for VRmagic’s Eyesi Surgical Medical Simulatorhttps://modernod.com/news/john-weiss-secures-exclusive-uk-distributorship-for-vrmagics-eyesi-surgical-medical-simulator/2478600/John Weiss & Son has announced it has secured an exclusive distributorship for the VRmagic Eyesi Surgical medical simulator. VRmagic was established in 2001 and is a provider of virtual and augmented reality technology in medical training. The solutions developed by VRmagic permit a re
- Eluminex Biosciences Announces Closing of $50 Million Series A Financinghttps://modernod.com/news/eluminex-biosciences-announces-closing-of-50-million-series-a-financing/2478597/China-based Eluminex Biosciences announced the completion of a $50 million Series A Financing, which will be used to develop a pipeline addressing critical unmet medical needs in vision-threatening diseases for patients. The financing was co-led by Lilly Asia
- Moderna’s mRNA COVID-19 Vaccine 94.1% Effective at Final Analysishttps://modernod.com/news/modernas-mrna-covid-19-vaccine-94-1-effective-at-final-analysis/2478596/Moderna announced Monday that the primary efficacy analysis of the phase 3 COVE study showed that its experimental mRNA-based COVID-19 vaccine mRNA-1273 had an efficacy rate of 94.1%, confirming the level observed at the first interim analysis. The company noted that the latest data were based on
- UK Government Asks Regulator to Clear “Temporary Supply” of AstraZeneca’s COVID-19 Vaccinehttps://modernod.com/news/uk-government-asks-regulator-to-clear-temporary-supply-of-astrazenecas-covid-19-vaccine/2478594/The UK government on Friday said that it formally asked the Medicines and Healthcare products Regulatory Agency (MHRA) to assess the suitability of AstraZeneca’s COVID-19 vaccine candidate AZD1222 for “temporary supply.” Health and Social Care Secretary Matt Hancock noted that t
- CORE and Myopia Profile Form Alliance to Expand Clinical Research and Professional Education Capabilitieshttps://modernod.com/news/core-and-myopia-profile-form-alliance-to-expand-clinical-research-and-professional-education-capabilities/2478595/The Centre for Ocular Research & Education (CORE) and Myopia Profile announced an alliance designed to expand both organizations’ services and reach. The affiliation aims to grow CORE’s extensive clinical research capabilities, adding expertise in specialty lenses, gas permeable, orthokerato
- Prediabetes Linked to Macular Thinninghttps://modernod.com/news/prediabetes-linked-to-macular-thinning/2478592/Prediabetes is associated with significant thinning of the macula and with decreases in retinal-artery diameters, according to a population-based study. Various retinal changes have been reported in individuals with impaired fasting glucose or hyperglycemia, but it remains unclear whether
- Topcon Announces the European Launch of Chronoshttps://modernod.com/news/topcon-announces-the-european-launch-of-chronos/2478579/Topcon Healthcare announced the European launch of the Chronos Automated Binocular Refraction System with SightPilot guided refraction software. Topcon Chronos is a complete digital refraction solution that combines autorefraction, keratometry, and subjective refraction in a single device.
- Wayne State Researchers Identify Cornea as a Potential Carrier of COVID-19https://modernod.com/news/wayne-state-researchers-identify-cornea-as-a-potential-carrier-of-covid-19/2478580/Scientists in the Department of Ophthalmology, Visual and Anatomical Sciences at the Wayne State University School of Medicine in Detroit have revealed that COVID-19 patients might harbor the virus in their eyes, demanding screening of ocular tissues before transplant surgeries during the pandemi
- Data Confirm Immune Response From AstraZeneca’s COVID-19 Vaccine in Elderlyhttps://modernod.com/news/data-confirm-immune-response-from-astrazenecas-covid-19-vaccine-in-elderly/2478582/Study results published in The Lancet suggest that the chimpanzee adenovirus-vectored COVID-19 vaccine being developed by AstraZeneca and the University of Oxford is able to produce a strong immune response in older adults, whilst being better tolerated in this age group than compared wi
- Eversight-Led Research Confirms Presence of SARS-CoV-2 in Postmortem Ocular Tissuehttps://modernod.com/news/eversight-led-research-confirms-presence-of-sars-cov-2-in-postmortem-ocular-tissue/2478578/Eversight announced research findings showing a small but noteworthy prevalence of SARS-CoV-2 in ocular tissues from individuals who died from COVID-19. The findings were presented Nov. 7 at the